Literature DB >> 17257675

Expression of the IFN-inducible p53-target gene TRIM22 is down-regulated during erythroid differentiation of human bone marrow.

Susanna Obad1, Tor Olofsson, Nadir Mechti, Urban Gullberg, Kristina Drott.   

Abstract

The interferon inducible protein TRIM22 has been identified as a p53 target gene, with possible involvement in proliferation and differentiation of leukaemia cells. Here, the expression levels of TRIM22 during haematopoietic differentiation are characterised. Expression of TRIM22 correlates inversely to differentiation, as TRIM22 is highly expressed in CD34(+) human bone marrow progenitor cells, but declines in mature populations. The erythroid lineage appears as a special case, as TRIM22 expression shows an extreme decrease during late erythroid maturation and is completely undetectable in nucleated erythroid populations in contrast to other lineages. In conclusion, our data could suggest lineage-specific roles for TRIM22 during haematopoietic differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17257675     DOI: 10.1016/j.leukres.2006.12.012

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  11 in total

1.  Induction of TRIM22 by IFN-γ Involves JAK and PC-PLC/PKC, but Not MAPKs and pI3K/Akt/mTOR Pathways.

Authors:  Bo Gao; Wei Xu; Yaxin Wang; Linmao Zhong; Sidong Xiong
Journal:  J Interferon Cytokine Res       Date:  2013-05-09       Impact factor: 2.607

2.  Estrogen induced breast cancer is the result in the disruption of the asymmetric cell division of the stem cell.

Authors:  Jose Russo; Kara Snider; Julia S Pereira; Irma H Russo
Journal:  Horm Mol Biol Clin Investig       Date:  2010-01-01

3.  An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma.

Authors:  Wei Xiong; Xiaosong Wu; Sarah Starnes; Sarah K Johnson; Jeff Haessler; Siqing Wang; Lijuan Chen; Bart Barlogie; John D Shaughnessy; Fenghuang Zhan
Journal:  Blood       Date:  2008-03-12       Impact factor: 22.113

4.  TRIM22 inhibits the TRAF6-stimulated NF-κB pathway by targeting TAB2 for degradation.

Authors:  Hui Qiu; Fang Huang; Han Xiao; Binlian Sun; Rongge Yang
Journal:  Virol Sin       Date:  2013-06-26       Impact factor: 4.327

5.  Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease.

Authors:  Qi Li; Cheng Hiang Lee; Lauren A Peters; Lucas A Mastropaolo; Cornelia Thoeni; Abdul Elkadri; Tobias Schwerd; Jun Zhu; Bin Zhang; Yongzhong Zhao; Ke Hao; Antonio Dinarzo; Gabriel Hoffman; Brian A Kidd; Ryan Murchie; Ziad Al Adham; Conghui Guo; Daniel Kotlarz; Ernest Cutz; Thomas D Walters; Dror S Shouval; Mark Curran; Radu Dobrin; Carrie Brodmerkel; Scott B Snapper; Christoph Klein; John H Brumell; Mingjing Hu; Ralph Nanan; Brigitte Snanter-Nanan; Melanie Wong; Francoise Le Deist; Elie Haddad; Chaim M Roifman; Colette Deslandres; Anne M Griffiths; Kevin J Gaskin; Holm H Uhlig; Eric E Schadt; Aleixo M Muise
Journal:  Gastroenterology       Date:  2016-02-04       Impact factor: 22.682

6.  TRIM22: A Diverse and Dynamic Antiviral Protein.

Authors:  Clayton J Hattlmann; Jenna N Kelly; Stephen D Barr
Journal:  Mol Biol Int       Date:  2012-05-08

7.  Human single-nucleotide polymorphisms alter p53 sequence-specific binding at gene regulatory elements.

Authors:  Omari J Bandele; Xuting Wang; Michelle R Campbell; Gary S Pittman; Douglas A Bell
Journal:  Nucleic Acids Res       Date:  2010-09-03       Impact factor: 16.971

8.  TRIM22-Mediated Apoptosis is Associated with Bak Oligomerization in Monocytes.

Authors:  Chi Chen; DongYan Zhao; Shu Fang; QiXing Chen; BaoLi Cheng; XiangMing Fang; Qiang Shu
Journal:  Sci Rep       Date:  2017-01-12       Impact factor: 4.379

9.  Tripartite Motif 22 (TRIM22) protein restricts herpes simplex virus 1 by epigenetic silencing of viral immediate-early genes.

Authors:  Tejaswini S Reddi; Philipp E Merkl; So-Yon Lim; Norman L Letvin; David M Knipe
Journal:  PLoS Pathog       Date:  2021-02-01       Impact factor: 6.823

10.  The interferon response inhibits HIV particle production by induction of TRIM22.

Authors:  Stephen D Barr; James R Smiley; Frederic D Bushman
Journal:  PLoS Pathog       Date:  2008-02-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.